All Comments by James Nicoll
- What About the Brain Shrinkage Seen with Aβ Removal?
- Alzheimer disease neuropathology in a patient previously treated with aducanumab.
- Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat.
- PET Firms Up Amyloid Cascade: Plaques, Inflammation, Tangles
- Donanemab Confirms: Clearing Plaques Slows Decline—By a Bit
- Paper Alert: Those PIGs! Spatial Transcriptomics Add Human Data
- Dale Schenk, 59, Pioneer of Alzheimer’s Immunotherapy
- Brain Drain—“Glymphatic” Pathway Clears Aβ, Requires Water Channel
- Bapineuzumab Crops CSF Tau Levels
- Testing the right target and right drug at the right stage.
- AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons
- Hypertension Begets Aβ, Begets Cardiovascular Damage
- Philadelphia: Can a Shrinking Brain Be Good for You?